Halozyme Expands argenx Collaboration for Subcutaneous Formulations

Halozyme announced an expansion of its global collaboration and license agreement with argenx. This expansion will support the development of subcutaneous formulations for two additional exclusive targets using Halozyme's ENHANZE® Technology.